^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

davoceticept (ALPN-202)

i
Other names: ALPN-202, ALPN 202
Associations
Trials
Company:
Alpine Immune Sci
Drug class:
CTLA4 antagonist, CD28 stimulant, PD-L1 antagonist
Associations
Trials